Targeting Abnormal Signals May Be New Method to Treat a Childhood Blood Disease
Oct 25, 2018
Blocking disease-causing biological signals may lead to a new treatment for the life-threatening childhood blood disorder Fanconi anemia.
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Oct 25, 2018
Blocking disease-causing biological signals may lead to a new treatment for the life-threatening childhood blood disorder Fanconi anemia.
Oct 10, 2018
CHOP’s pediatric malnutrition screening tool could be implemented to screen all pediatric patients.
Oct 5, 2018
The $220,000 award will be directed to a Phase I clinical trial that will investigate the effectiveness of CAR T-cell therapy to treat AML.
Oct 2, 2018
Proceeds from the event will support breakthroughs in pediatric cancer research and care at Children's Hospital of Philadelphia.
Jan 24, 2019
Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.
Sep 28, 2018
Hyundai Hope on Wheels Awards CHOP with Hyundai Hope Scholar and Young Investigator Grant to support pediatric cancer research.
Sep 17, 2018
CHOP patient family credits faith and doctors for recovery and donates $50,000 to Children's Hospital of Philadelphia.
Sep 10, 2018
The new research platform will make large-scale data on childhood cancer and birth defects available to researchers, clinicians and patients within a cloud-based environment.
Sep 5, 2018
Children’s Hospital of Philadelphia was recognized specifically for significant contributions to the development of a new treatment for a certain pediatric leukemia.
Aug 24, 2018
The European Commission (EC) approves Kymriah, the first-ever U.S. FDA approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers.